• U.S. Code
  • Regulations
  • Constitution
x
Search guide

U.S. Code of Federal Regulations

Regulations most recently checked for updates: Aug 27, 2025

All TitlesTitle 21Chapter IPart 330Subpart B - Subpart B—Administrative Procedures
§ 330.10 - Procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded, and for establishing monographs.
§ 330.11 - NDA deviations from applicable monograph.
§ 330.12 - Status of over-the-counter (OTC) drugs previously reviewed under the Drug Efficacy Study (DESI).
§ 330.13 - Conditions for marketing ingredients recommended for over-the-counter (OTC) use under the OTC drug review.
§ 330.14 - Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded.
§ 330.15 - Timelines for FDA review and action on time and extent applications and safety and effectiveness data submissions.
© 2016 GovRegs | About | Disclaimer | Privacy
Download the GovRegs app!